What is Glutathione?
Glutathione (abbreviated GSH) is a tripeptide consisting of three amino acids: L-glutamate, L-cysteine, and glycine. Unlike most peptides, the glutamate residue connects to cysteine via its gamma-carboxyl group (not the standard alpha-carboxyl), giving glutathione a distinctive peptide bond that makes it more resistant to cleavage by most peptidases. This unusual linkage is part of what allows glutathione to be stable inside cells.
Glutathione is produced endogenously in virtually every cell of the body, with the highest concentrations found in the liver, where it plays a central role in detoxification. It is the most abundant low-molecular-weight antioxidant in mammalian cells — intracellular concentrations typically range from 1–10 mM, orders of magnitude higher than most other antioxidants. This concentration reflects its critical importance: glutathione is not a trace antioxidant but a central redox buffer that the cell maintains at all times.
The molecule's antioxidant function depends on a single reactive site: the thiol group (–SH) on the cysteine residue. This sulfur-hydrogen bond can donate electrons to neutralize reactive oxygen species (ROS), become oxidized in the process, and then be regenerated — making glutathione a reusable, catalytic antioxidant rather than a consumable one.
| Property | Value |
|---|---|
| Composition | γ-L-glutamyl-L-cysteinylglycine (Glu-Cys-Gly) |
| Molecular weight | 307.3 Da |
| Intracellular concentration | 1–10 mM (one of the highest of any cellular molecule) |
| Functional site | Cysteine thiol group (–SH) |
| Highest tissue concentration | Liver (hepatocytes), erythrocytes, lens epithelium |
| J.Pharma form | Lyophilized powder, 600mg vial |
| Reconstitution | 3 mL BAC Water → 200 mg/mL · light-sensitive |
The GSH / GSSG Redox Cycle
The term "master antioxidant" refers not only to glutathione's direct ROS-scavenging activity but to its role as the hub of the cellular antioxidant system. Understanding this requires understanding the cycle it operates in.
In its reduced form, GSH (the active antioxidant) carries the free thiol group. When GSH donates electrons to neutralize hydrogen peroxide (H₂O₂) or lipid peroxides — catalyzed by the enzyme glutathione peroxidase (GPx) — the thiol group is oxidized. Two GSH molecules combine to form one molecule of GSSG (oxidized glutathione), with a disulfide bridge between the two cysteine residues.
GSSG is inactive as an antioxidant. To restore the antioxidant capacity of the cell, GSSG must be reduced back to two molecules of GSH. This is accomplished by the enzyme glutathione reductase, using NADPH as the electron donor. NADPH itself comes primarily from the pentose phosphate pathway (specifically the glucose-6-phosphate dehydrogenase step). This means the cell's antioxidant capacity is ultimately tied to glucose metabolism — a connection that explains why metabolic dysfunction can amplify oxidative stress.
The GSH:GSSG ratio is widely used as a marker of cellular redox status. Under normal conditions, this ratio is approximately 100:1 (mostly GSH). A shift toward more GSSG signals oxidative stress and can trigger downstream responses including NF-κB activation, apoptotic signaling, and protein oxidation.
| Step | Reactants | Products | Enzyme |
|---|---|---|---|
| ROS neutralization | 2 GSH + H₂O₂ | GSSG + 2 H₂O | Glutathione peroxidase (GPx) |
| Regeneration | GSSG + NADPH + H⁺ | 2 GSH + NADP⁺ | Glutathione reductase (GR) |
| NADPH supply | Glucose-6-phosphate + NADP⁺ | 6-phosphogluconolactone + NADPH | Glucose-6-phosphate dehydrogenase (G6PD) |
Glutathione as the Antioxidant Network Hub
The designation "master antioxidant" carries a second meaning: glutathione recycles other antioxidants that would otherwise be consumed and lost. This network effect multiplies its impact far beyond its direct ROS-scavenging capacity.
Vitamin C (ascorbate) neutralizes ROS and is oxidized to dehydroascorbate in the process. Glutathione donates electrons to regenerate ascorbate from dehydroascorbate, via an enzyme called dehydroascorbate reductase (or non-enzymatically at physiological concentrations). Without this regeneration step, vitamin C would be rapidly depleted.
Vitamin E (alpha-tocopherol) is the primary lipid-phase antioxidant, residing in cell membranes where it neutralizes lipid peroxyl radicals. After donating an electron, vitamin E becomes the tocopheroxyl radical — which is then regenerated by vitamin C. The chain thus runs: Vitamin E → neutralizes lipid radicals → Vitamin C regenerates Vitamin E → Glutathione regenerates Vitamin C → Glutathione reductase + NADPH regenerates Glutathione. Cut any link and the whole system degrades.
Glutathione is the ultimate electron sink that keeps this entire chain cycling. This is the mechanistic basis for the "master antioxidant" designation.
Phase II Liver Detoxification
The liver processes toxins through two phases. Phase I (primarily cytochrome P450 enzymes) oxidizes, reduces, or hydrolyzes compounds to make them more reactive. This often creates electrophilic intermediates that are actually more chemically dangerous than the original compound — if not quickly processed by Phase II.
Phase II detoxification neutralizes these reactive intermediates by conjugating them with endogenous molecules, making them water-soluble enough to excrete. Glutathione is the primary Phase II conjugation substrate. A family of enzymes called glutathione S-transferases (GSTs) catalyze the conjugation of GSH to electrophilic compounds — including drug metabolites, environmental pollutants (polycyclic aromatic hydrocarbons, pesticides), heavy metals, and endogenously generated oxidation products.
The glutathione conjugate is further processed: the glutamate and glycine residues are cleaved, and the remaining cysteine conjugate is acetylated to form a mercapturic acid. This mercapturic acid is water-soluble and is excreted primarily in urine and bile. This pathway — called the mercapturic acid pathway — handles a remarkable range of otherwise difficult-to-excrete compounds and is central to the liver's xenobiotic processing capacity.
Hepatic glutathione depletion (from heavy toxic load, oxidative stress, or malnutrition) significantly impairs Phase II capacity and can result in accumulation of reactive Phase I intermediates, increasing hepatocellular damage risk. This is one reason glutathione status is a marker of overall liver health in research models.
| Compound class | GST conjugation example | Result |
|---|---|---|
| Drug metabolites | Acetaminophen reactive metabolite (NAPQI) | GSH conjugate → mercapturic acid → excreted |
| Environmental pollutants | Polycyclic aromatic hydrocarbons, epoxides | Detoxified, water-soluble conjugate |
| Heavy metals | Mercury, arsenic, cadmium | GSH chelation → biliary/urinary excretion |
| Endogenous lipid peroxides | 4-Hydroxynonenal (4-HNE) | GSH adduct formation → export via MRP transporters |
| Reactive aldehydes | Malondialdehyde (MDA) | GSH conjugation, reduces DNA damage potential |
Glutathione & Melanogenesis
Melanin is synthesized in melanocytes through the melanogenesis pathway, starting from the amino acid tyrosine. The first and rate-limiting step is the oxidation of tyrosine to DOPA, catalyzed by tyrosinase — a copper-containing enzyme. This initial step is the major control point for regulating how much melanin is made and what type.
The pathway branches at DOPA-quinone: toward eumelanin (brown/black) in the presence of sulfhydryl-free conditions, or toward pheomelanin (red/yellow) when cysteine or glutathione is present to donate sulfhydryl groups. Glutathione shifts this branch point by reacting with DOPA-quinone to form glutathionyl-DOPA — an intermediate that enters the pheomelanin pathway rather than the eumelanin pathway. The result is reduced production of dark pigment.
Glutathione also inhibits tyrosinase through a secondary mechanism: it can chelate the copper cofactor at tyrosinase's active site, reducing the enzyme's activity directly. This dual action — branch-point diversion and enzyme inhibition — has made glutathione a well-studied subject in dermatological pigmentation research.
Research using injectable glutathione has documented reduced melanin index and skin lightening in animal and cell models. The injectable route is of particular research interest because oral glutathione is substantially degraded in the gastrointestinal tract before reaching circulation, whereas parenteral delivery bypasses first-pass metabolism entirely.
| Mechanism | Effect on melanogenesis |
|---|---|
| DOPA-quinone + GSH → glutathionyl-DOPA | Diverts pathway toward pheomelanin (lighter pigment) |
| Copper chelation at tyrosinase active site | Reduces tyrosinase enzymatic activity |
| Reduced DOPA / eumelanin precursor availability | Less dark eumelanin produced |
| Antioxidant suppression of ROS-stimulated melanogenesis | UV-induced melanogenesis partially ROS-dependent |
Glutathione & Immune Cell Function
Immune cells are among the most metabolically active cells in the body and generate significant ROS as part of their normal function — particularly during the oxidative burst used to kill pathogens. Maintaining adequate intracellular glutathione is essential for immune cells to survive their own oxidative activity and continue functioning.
Research has shown that lymphocyte proliferation, NK (natural killer) cell cytotoxicity, and antigen presentation by dendritic cells are all sensitive to intracellular GSH levels. Glutathione-depleted lymphocytes show impaired proliferative responses and reduced cytokine production. Conversely, elevated intracellular GSH has been associated with enhanced T-cell activation in some research models.
Glutathione also plays a role in regulating inflammatory signaling. NF-κB, the master transcription factor for pro-inflammatory cytokine production, is redox-sensitive — oxidative conditions promote its activation. Glutathione-mediated reduction of ROS can modulate NF-κB activity, positioning glutathione at the intersection of antioxidant and anti-inflammatory research.
Reconstitution Protocol
Glutathione 600mg ships as lyophilized powder. Reconstitute with 3 mL Bacteriostatic Water for a working concentration of 200 mg/mL. Inject BAC water slowly down the vial wall and swirl gently — do not shake. The solution should dissolve completely and appear clear to very slightly yellow.
For full protocols: Reconstitution Guide · Dosing Calculator · How to Reconstitute Peptides